Prevalence, duration and indications for prescribing of antidepressants in primary care
The DOI matches its Crossref record; 8 of the 9 references it cites were found in a registry or an index.
Abstract
SIR—Depression is thought to occur in 10% of the adult population in Britain at any one time [1]. In older people, the incidence of depression rises to 15% [2]. We know that the volume of antidepressants prescribed in English primary care, where most people receive treatment for depression, has increased substantially over recent years [3, 4], but there are no data on the prevalence of antidepressant prescribing at patient level and the extent of continuation of prescribing in individual patients. Guidelines suggest withdrawal of antidepressants after 6 months of effective treatment [5], but long-term prescribing (2 years or more) may be appropriate if the illness is chronic or relapsing. A more worrying reason for long-term prescribing would be difficulty with stopping antidepressants because of unpleasant withdrawal reactions. Patients may also remain on treatment by therapeutic momentum—because the prescriber does not suggest or attempt withdrawal or does not review the continuing need for the medicine. We aimed to identify the frequency of antidepressant prescribing in a typical English Primary Care Trust, how long these medicines were prescribed for and the reasons for long-term prescribing. North Bradford PCT has a population of about 94,000 in a socioeconomically mixed urban and suburban area. The population is predominantly white British. There are 12 general practices, of which 11 (population of 81,221 in 2002) have clinical databases that allow suitable searches and were included in the study. Each practice database was searched for antidepressant prescriptions (acute or repeat) issued in the quarters commencing April 2002 and April 2004. An antidepressant was defined as any drug appearing in British National Formulary (BNF) section 4.3: antidepressants. The 2002 cohort was addressed to identify those being prescribed antidepressants in the quarter commencing April 2004. Separate searches were made for tricyclic antidepressants (TCAs) (BNF section 4.3.1), selective serotonin reuptake inhibitors (SSRIs) (4.3.3) and ‘other antidepressants’ [e.g. venlafaxine (4.3.4)]. For the second phase of the study, we took a sample of 140 patients (representing 5% of those who had been prescribed an antidepressant in both 2002 and 2004) to answer questions about how long patients had been prescribed antidepressants, the reason for prescribing and whether a review occurred. We based our sample size on the proportion of those who been prescribed a TCA, rather than another type of antidepressant. In our population, that rate was 48%. Taking a sample of 140 patients would give a population estimate with 95% confidence intervals within 8% of the actual figure, which we interpreted as being sufficiently accurate. A diagnosis was sought from information in general practitioner records and hospital letters. The number of consultations with the general practitioner over a 2-year period was recorded. Evidence was sought from each consultation as to whether this was for a mental health reason. Evidence was also sought as to whether the patient was under review by a psychiatrist. The first antidepressant ever prescribed for the individual, the final antidepressant prescribed (up to April 2004) and the number of drug or dose changes between these two time periods were recorded. The rates of antidepressant prescribing in 2002 and 2004 are summarised in Table 1. The prescribing rates among the practices did not change between 2002 and 2004. Four per cent of males and 9% females were prescribed an antidepressant in 2004. In total 72% of those prescribed an antidepressant were females. Antidepressant prescribing in 11 general practices: 2002 and 2004 Antidepressant prescribing in 11 general practices: 2002 and 2004 Of those prescribed an antidepressant in 2002, 48% (2,711/5,648) (practice range 33–55%) were still prescribed one in 2004. The continuation rate varied by antidepressant type (TCA 48%, SSRI 36% and ‘other antidepressants’ 45%), with the SSRI rate significantly lower than that of TCAs and ‘other’ (Wilcoxon signed rank test z = 2.93, P = 0.003, and z = 2.76, P = 0.006, respectively). The mean duration of prescribing of antidepressants for those who were prescribed antidepressants in both 2002 and 2004 for different indications ranged from 4.8 to 7.7 years (Table 2). Indication for patients prescribed an antidepressant in both 2002 and 2004 (phase 2 sample) Indication for patients prescribed an antidepressant in both 2002 and 2004 (phase 2 sample) The mean age of the 5% sample (140 patients) was 59 years and 72% (101/140) were female. This compares with 72% in the total population and an average age of 57 years. The mean number of general practitioner consultations was 11 over the 2-year period April 2002 to June 2004 (range 1–53). All subjects had at least one consultation with their general practitioner in the 2-year period. Despite this, 21% (30/140) [22/87 (25%) TCAs and 8/53 (15%) SSRIs] had no documented mental hea
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the mean duration of antidepressant treatment is longer than two years in the UK (Johnson 2012: Petty 2006), four years in Australia (Kjosavik 2016), and longer than five years in the United States (Mojtabi 2014; Pratt 2011).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Petty 2006
Citations
Cites
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
Review of community prevalence of depression in later life
Beekman, A. T. F., Copeland, J., & Prince, M. J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.307 · Cited by 1,144
Secular trends in antidepressant prescribing in the UK, 1975-1998
Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001) · Journal of Public Health · doi:10.1093/pubmed/23.4.262 · Cited by 168
Lawrenson, R., Tyrer, F., Newson, R. B., & Farmer, R. D. T. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00147-0 · Cited by 165
Clinical management of antidepressant discontinuation.
Rosenbaum, J. F., & Zajecka, J. (1997) · PubMed · Cited by 99
Zermansky, A. G. (1996) · Europe PMC (PubMed Central) · Cited by 98
Self-citationAntidepressant drug prescribing among elderly subjects: a population-based study
Percudani, M., Barbui, C., Fortino, I., & Petrovich, L. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1259 · Cited by 50
Natural history of pharmacotherapy of older depressed community residents: The MRC–ALPHA Study
Wilson, K. C. M., Copeland, J. R. M., Taylor, S., & Donoghue, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.439 · Cited by 29
Cited by
Items 101–109 of 109
Arnold, I. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6605 · Cited by 1
The serotonin theory of depression: how the media got it all wrong
(2022) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2022.1.153955 · Cited by 1
Vasquez-Goñi, G. A. J., & Romero, B. M. P. (2022) · Universidad Científica del Sur · doi:10.21142/tl.2022.2293
Kendrick, T., Stuart, B. L., Bowers, H. M., Sadeghi, M. H., Hl, P., Dowrick, C. F., Moore, M. V., Gabbay, M., Leydon, G., Yao, G., et al. (2025) · Programme Grants for Applied Research · doi:10.3310/btbl3945 · Cited by 1
Ambagtsheer, R. C., Archibald, M. M., Lawless, M., Kitson, A., & Beilby, J. (2020) · Figshare · doi:10.6084/m9.figshare.12178185
Rosado, D. C. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Lerma, K. E. P., Alcantara-Diaz, A. L., Salazar-Talla, L., Urrunaga‐Pastor, D., Runzer-Colmenares, F. M., & Parodi, J. F. (2026) · Geriatric Nursing · doi:10.1016/j.gerinurse.2026.103879
Loayza-Gonzales, R. R., Portal-Pasquel, P. A., Salazar-Talla, L., Urrunaga‐Pastor, D., Clain-Martins, R., Runzer-Colmenares, F. M., & Parodi, J. F. (2026) · Medical Education & Clinical Practice · doi:10.21142/mecp.2026.1.2.e019
“An affirmative response defined the presence of this criterion [21] .”
Why did antidepressant deprescribing fail? A scoping review of contributing factors
Ayed, E., Gerard, E., Quindroit, P., Martino, C. D., Lamer, A., Bubrovszky, M., Baran, J., Calafiore, M., Standaert‐Vitse, A., & Beuscart, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-115482
Metadata
- Authors
- Petty, D. R., House, A., Knapp, P., Raynor, T., & Zermansky, A.
- Affiliations
- University of Leeds (GB)
- Corresponding author
- Petty, Duncan Robert
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-11
- Volume
- 35
- Issue
- 5
- Pages
- 523-526
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2171692621
- Cited by
- 110
- References
- 9
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 3 · 2023: 1 · 2022: 7 · 2021: 14 · 2020: 15 · 2019: 10 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 4 · 2012: 5
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Age and Ageing (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- antidepressant prescribing, depression, long-term prescribing, antidepressant discontinuation, selective serotonin reuptake inhibitors, tricyclic antidepressants, venlafaxine, prescription review, primary care, patient information leaflets, prescribing guidelines adherence, England, chronic depression
- MeSH terms
- Aged, Antidepressive Agents, Anxiety, Depression, Drug Utilization, England, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Pain, Primary Health Care, Drug Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.